Cantor Fitzgerald’s Insmed INSM Stock Holding History

Cantor Fitzgerald’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.67M	Buy	25,000 +14,000	+127%	+$1.7M	0.03%	167
2026 Q1	$1.8M	Buy	+11,000	New	+$1.69M	0.03%	158
2025 Q2	–	Sell	-5,060	Closed	-$386K	–	493
2025 Q1	$386K	Sell	5,060 -4,940	-49%	-$378K	0.01%	168
2024 Q4	$682K	Buy	+10,000	New	+$720K	0.01%	103

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Cantor Fitzgerald's INSM Position: Q2 2026 in Review

Cantor Fitzgerald increased its Insmed (INSM) stake by 127% in Q2 2026, buying an estimated $1.7M and bringing the position to 25,000 shares worth $2.67M. The position accounts for 0.03% of the portfolio, ranked #167.

Cantor Fitzgerald first reported a position in INSM in Q4 2024 and has held it in 4 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Cantor Fitzgerald held 25,000 shares of Insmed worth $2.67M as of Q2 2026.
Cantor Fitzgerald bought 14,000 Insmed shares in Q2 2026, an estimated $1.7M.
Insmed made up 0.03% of Cantor Fitzgerald's portfolio in Q2 2026, its #167 holding.
Cantor Fitzgerald first reported a position in Insmed in Q4 2024 and has held it in 4 quarters since.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.